Showing results (1501-1510 of 6,507) with videos related to

Sort By:
Pageof 651
Cancer Immunology, Immunotherapy : CII|September 14, 2023
Anti-CD79b/CD3 bispecific antibody combined with CAR19-T cells for B-cell lymphoma treatmentWei-Wei Zheng, Hang Zhou, Ping Li, et al.
Cancer Immunology, Immunotherapy : CII|August 29, 2023
Cancer management during the COVID-19 world pandemicNavid Sobhani, Giuseppina Mondani, Giandomenico Roviello, et al.
Cancer Immunology, Immunotherapy : CII|August 19, 2023
HLA-B*44 and the Bw4-80T motif are associated with poor outcome of relapse-preventive immunotherapy in acute myeloid leukemiaHana Komic, Alexander Hallner, Brwa Ali Hussein, et al.
Cancer Immunology, Immunotherapy : CII|August 19, 2023
Intravenous injection of tumor extracellular vesicles suppresses tumor growth by reducing the regulatory T cell phenotypeSanshiro Kobayashi, Naoyuki Kondo, Takashi Tomiyama, et al.
Cancer Immunology, Immunotherapy : CII|January 17, 2024
Rescue of NLRC5 expression restores antigen processing machinery in head and neck cancer cells lacking functional STAT1 and p53Brendan L C Kinney, Sreenivasulu Gunti, Vikash Kansal, et al.
Cancer Immunology, Immunotherapy : CII|January 17, 2024
Generation and assessment of cytokine-induced killer cells for the treatment of colorectal cancer liver metastasesCeline Man Ying Li, Yoko Tomita, Bimala Dhakal, et al.
Cancer Immunology, Immunotherapy : CII|January 17, 2024
Bone marrow-derived mesenchymal stromal cells obstruct AML-targeting CD8+ clonal effector and CAR T-cell function while promoting a senescence-associated phenotypeRussell Towers, Lidia Trombello, Maximilian Fusenig, et al.
Cancer Immunology, Immunotherapy : CII|January 17, 2024
Allogeneic CAR-T cells with of HLA-A/B and TRAC disruption exhibit promising antitumor capacity against B cell malignanciesXinfeng Chen, Binghe Tan, Haizhou Xing, et al.
Pageof 651